Home / Investor Relations / CEO Commentaries

CEO Commentaries

SARS-CoV-2 virus

Bridging Corona

As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
Read More

Joining forces with Huntsman

PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop methods quantifying the phenomena known as epithelial–mesenchymal transition (EMT).
Read More
Single-cell analysis using supercomputers

The Single-Cell Analysis Revolution

Single-cell analysis aided by supercomputing and artificial intelligence is set to revolutionize biomedical research over the next decade.
Read More
Primary cell with varying morphology imaged with HoloMonitor.

National Institutes of Health Purchase HoloMonitor

Using HoloMonitor’s unique capability to non-invasively image and quantify cellular behavior over long time periods, scientists at the National Institute of Aging aim to understand how the heart’s “brain cells” contribute to aging.
Read More
BRAF Mutation

Understanding skin cancer

Using HoloMonitor and the latest gene editing techniques, scientists at University of California, San Francisco have uncovered the mechanisms leading to invasive melanoma.
Read More

Redefining Aging With HoloMonitor

By studying a primitive form of bacteria researchers at Queensland University of Technology in Australia have developed a new drug that has the potential to dramatically slow the aging process. Using HoloMonitor the researchers could see how old and damaged cells became young again. The promising results were recently reported by Australian television.
Read More